Guidance on Standardizing Terminology and Collection: Another Step in FDA’s Path to Increasing Diversity and Inclusion in Clinical Trials By Deborah L. Livornese —

https://www.thefdalawblog.com/2024/02/guidance-on-standardizing-terminology-and-collection-another-step-in-fdas-path-to-increasing-diversity-and-inclusion-in-clinical-trials/?utm_source=rss&utm_medium=rss&utm_campaign=guidance-on-standardizing-terminology-and-collection-another-step-in-fdas-path-to-increasing-diversity-and-inclusion-in-clinical-trials